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Abstract
Preventing obesity could be done by lowering plasma TAG that inhibits adipogenesis. Oat and mushroom
beta-glucans in the diet has been reported to lower plasma lipid; however the data focusing on their
effects on TAG and obesity are insufficient. In the present study, lowering plasma triacylglycerol, fat
deposition, body weight gain (BWG) in rats fed a high fat diet (HFD) was evaluated. Rats in the control
group were given HFD only and rats in the treatment group fed HFD enriched with 0.2%, 0.6% and 1.8%
(wt:wt) beta-glucan from oats (LD-O, MD-O, HD-O) or mushroom (LD-M, MD-M, HD-M). After 6 weeks
dietary intervention, the rats fed HD-M showed significantly lower plasma TAG, total fat mass, white
adipose tissue, inguinal fat and BWG level more than HD-O treated rats (p < 0.05). The underlying
mechanism in lowering plasma TAG, fat pad masses and BWG in HD-M was increasing ratio of fat faecal
to faecal weight which was significantly higher than HD-O (p < 0.05). This study demonstrated that the
preventing obesity via lowering plasma TAG and fat deposition was different depending on beta-glucan
origin, either from oats and Shiitake mushroom.
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ABSTRACT
Preventing obesity could be done by lowering plasma TAG that inhibits adipogenesis. Oat and mushroom beta-glucans
in the diet has been reported to lower plasma lipid; however the data focusing on their effects on TAG and obesity are
insufficient. In the present study, lowering plasma triacylglycerol, fat deposition, body weight gain (BWG) in rats fed a
high fat diet (HFD) was evaluated. Rats in the control group were given HFD only and rats in the treatment group fed
HFD enriched with 0.2%, 0.6% and 1.8% (wt:wt) beta-glucan from oats (LD-O, MD-O, HD-O) or mushroom (LD-M,
MD-M, HD-M). After 6 weeks dietary intervention, the rats fed HD-M showed significantly lower plasma TAG, total
fat mass, white adipose tissue, inguinal fat and BWG level more than HD-O treated rats (p < 0.05). The underlying
mechanism in lowering plasma TAG, fat pad masses and BWG in HD-M was increasing ratio of fat faecal to faecal
weight which was significantly higher than HD-O (p < 0.05). This study demonstrated that the preventing obesity via
lowering plasma TAG and fat deposition was different depending on beta-glucan origin, either from oats and Shiitake
mushroom.
Keywords: Beta-Glucan; Triacylglycerol; Fat Deposition; Obesity; Dietary Fibre

1. Introduction
In recent years, the prevalence of obesity has been widely
reported to induce metabolic syndrome, cardiovascular
disease, diabetes mellitus and cancer [1-3]. It has been
reported that lowering plasma triacylglycerol (TAG)
levels will be efficient in combating body weight gain as
an increased plasma TAG level was significantly correlated with increase in body mass index and fat pad masses
on rats [4]. Beta-glucan is well documented as lowering
plasma lipids in human [5-8] and animal [9,10] studies.
Oats and mushrooms have been found to be good
sources of beta-glucan. An enrichment diet of oats in a
clinical study was not reported to lower plasma TAG
levels [11-14] but lowered total plasma cholesterol (TC)
[11,13]. Limited human studies such as [15] have shown
the prevention of increased TAG plasma levels using a
mushroom enriched diet.
One of the mechanisms of oat beta-glucan in lowering
*

Corresponding author.

plasma lipid is its capacity to increase food viscosity [9,
10,16]. By increasing viscosity of food in the lumen,
beta-glucan was reported to prevent and delay the absorption of nutrients. However, the viscosity of beta-glucan is dependent on the molecular weight, molecular
structure, and food matrix [7,10,17].
While in nearly all of the reported research beta-glucan
was found to be the main component from oats with the
potential to lower plasma lipid, in contrast, in research
using the shiitake mushroom, not only was beta-glucan
reported to lower lipid, but other nutrient content such as
eritadenine also lowered plasma lipids [18-20]. Another
difference between oats and shiitake mushrooms is the
molecular structure of their beta-glucan [21].
Thus it will be predicted from compositional data that,
when comparable amounts of beta-glucan are consumed,
shiitake mushrooms will lower plasma lipid more effectively than oats. These predictions are supported by the
findings of an extraction of each component of shiitake
mushrooms; for instance, polysaccharide, and eritadenine
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lower plasma TAG by 15% [22], and 39% [23] respectively. Also reported exoskeleton mushroom contains
chitin-chitosan lower plasma TAG lipid by 32% [24].
To the best of our knowledge, no data are available to
examine the comparative effect of oats and shiitake
mushrooms in preventing body weight gain in a similar
designed study. Such a study would use equivalent dosages of beta-glucan for both the oat and mushroom
powder, and in addition, the same background high fat
diet (HFD) would be given and the same type of food
matrix used to administer the oats and mushrooms.
The aims of this research were to 1) compare the effect
of oats and mushrooms powder to prevent body weight
gain, 2) to determine the effective dose of oat and mushroom powder necessary to prevent body weight gain and
3) to determine the potential underlying mechanisms to
preventing body weight gain.

2. Material and Methods
2.1. Animals and Diet
Seventy male Wistar rats at 9 weeks of age were purchased from the Animal Resource Centre (ARC)-Perth,
Western Australia. All experimental procedures were
approved by the Animal Ethics Committee of the University of Wollongong, AE 09/01. The animals were
housed two rats per cage in environmentally controlled
conditions (temperature 22˚C, light cycle from 06:00 to
18:00 hours and dark cycle from 18:00 to 06:00 hours)
and had ad libitum access to food and water. Rats were
fed a commercial chow (rat and mouse YS Feed, Young,
NSW) in order to acclimatise to the new facility and environment. The seventy rats were divided into seven
groups (n = 10) and fed ~50% HFD with additional nil,
low, medium and high doses of oat powder and Shiitake
mushroom powder 1) HFD, 2) low dose oat (LD-O), 3)
medium dose oat (MD-O) and 4) high dose oat (HD-O),
5) low dose Shiitake mushroom (LD-M), 6) medium
dose Shiitake mushroom (MD-M), 7) high dose Shiitake
mushroom (HD-M). Oat bran powder was from OatWell®
Crea-nutrition and the Shiitake mushroom was from Shenzen Dashan, Food Stuff. Co. Ltd, Shanghai that was imported by a local store in Australia. The nutrient composition of the oats and mushrooms is shown in Table 1.
The low, medium and high doses of either oats or mushrooms contain beta-glucan that is comparable to 3, 9 and
27 g of the beta-glucan requirement for humans, respectively. The composition of the seven diets is shown in
Table 2.

2.2. Body Weight, Food Intake and Fat Pad
Masses
Animals were weighed weekly throughout the six week

intervention period. Food intake was measured every 24
hours by weighing the amount of total food (g) provided
to the rats and subtracting the remaining food (g) in the
cage after 24 hours.
After completion of food intervention, rats were sacrificed via carbon dioxide asphyxiation. The white adipose
tissue (WAT) comprised of visceral fat (epididymal, perirenal, and omental fat) and subcutaneous fat (inguinal
fat) were then removed and weighed.

2.3. Plasma Lipid Profile
Blood samples were obtained by puncturing the right
ventricle of the heart and collected in EDTA coated tubes
and centrifuged at 3000 rpm at 22˚C for 25 minute. High
density lipoprotein (HDL) was isolated from plasma with
dextran sulphate and magnesium chloride, based on a
modified method from Sjoblom and Eklund [25]. Total
plasma cholesterol (TC), TAG, high density lipoprotein
(HDL) and plasma Non Esterified Fatty acid (NEFA)
were measured using the Konelab® 20XT automatic analyser. The TC, TAG and HDL were analysed with InfinityTM reagent from Thermo Fisher Scientific (Auburn
NSW, Australia) and plasma NEFA were analysed use a
highly specific enzymatic (Wako Chemical, Richmond,
VA, USA).

2.4. Viscosity and Molecular Weight (MW) from
Oat and Mushroom Beta-Glucan
2.4.1. Extraction of Beta-Glucan
Beta-glucans were extracted from commercial varieties
of oats and shiitake mushrooms. Oats and Shiitake mushrooms were pulverized separately using a blender (Breville, Sydney, Australia) and sieved through 355 µm
mesh. Different concentrations of oats and mushrooms
(Table 3) were prepared by stirring a measured amount
of each powder in de-ionised water at 70˚C for 30 minutes. The suspensions were then centrifuged in a Sorvall
RC-5B centrifuge (DuPont Company, Wilmington, Delaware, USA) at 10,000 rpm for 30 minutes. The clear viscous supernatant solutions, containing extracted beta-glucans, were collected for viscosity measurement.
2.4.2. Viscosity Measurement
The apparent viscosity of the extract was determined at a
constant temperature of 37˚C, to mimic the human body
temperature, using a DV III Rheometer (Brookfield, Middleboro, Massachusetts, USA). A water-jacketed sample
cup was employed to maintain a constant sample temperature during the measurement. The speed of the rotating spindle was increased and then decreased to the
starting speed. The speeds were chosen so that the torque
exerted on the liquid was between the manufacturer’s
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Table 1. Nutrient information of OatWell® and Shiitake mushroom.
OatWella

Nutritive value
Chemical Properties

Vitamins and Minerals

Shiitake mushroom

Protein (g)

20

20b

Carbohydrate (g)

22

32.2b

Total dietary fiber (g)

44

33.3b

Beta-glucan soluble fibre (g)

22

30c

Fat (g)

5

0.7b

Energy Kcal or Kj

215/899

282/1178b

Sodium (Na) (mg)

8

30d

Magnesium (Mg) (mg)

250

1550 [26]

Calcium (Ca) (mg)

120

500 [26]

Potassium (K) (mg)

680

26.7 [26]

Iron (Fe) (mg)

11

33 [26]

Zinc (Zn) (mg)

6

92 [26]

Vitamin A (µg)

NA

NA

Vitamin B1(mg)

0.3

0.6 [26]

Vitamin B2 (mg)

NA

1.8 [26]

Vitamin B6 (mg)

0.9

NA

Vitamin B12 (µg)

NA

0.8 [26]

Folic Acid (µg)

44

640 [26]

Vitamin C (mg)

NA

25 [26]

Vitamin D (µg)

NA

1 µg [26]

Vitamin E (delta-alpha-tocopherol)

0.1 mg

NA

Saturated FA (g)

0.9

0.3d

Polyunsaturated FA (g)

2.0

NA

Monounsaturated FA (g)

2.1

NA

Molecular weight

DA = Dalton = g/Mol

1689.000 [27]

Other Active Components

Chitin (%)

Fatty Acids

Other Specification
>1689.000

-

5.36 [28]

Eritadenine (%)

-

0.3 - 0.63 [29]

Chitosan

-

a

®

Data as per 100 g on dry basis. Information based on product data sheet OatWell 22%-Crea Nutrition; bAnalysis
by Grain Growers Limited (NSW-Australia)/Acc. No. 66; cAnalysis with beta-glucan-glucan KIT from Megazyme
(K-YBGL 04/2008) (Victoria, Australia); dInformation based on nutrient fact sheet from Shiitake Mushroom Shenzhen Dashan Foodstuff Co. Ltd. NA: Not available.

recommended ranges of 10% to 100%. At a particular
speed, the viscosity was measured over the duration of
10 minutes. For the Shiitake mushroom beta-glucan, the
minimum and maximum speeds used were 35 rpm (shear
rate of 263 s–1) and 55 rpm (shear rate of 413 s–1), respectively, with an increment of 5 rpm. However, for the
concentration 2 mg/ml, the maximum speed possible
before the torque exceeded 100% was 45 rpm. For the
oat beta-glucan, since there was a significant difference
in viscosity with the change of concentration, the range
of speed that could be used (ensuring torque was between
10% - 100%) also differed considerably. For 3 mg/ml, 8

mg/ml, and 2.5 mg/ml, the speeds used varied from 20 to
55 rpm, 8 to 45 rpm, and 0.01 to 0.5 rpm, respectively.
2.4.3. Determination of Molecular Weight
Molecular weights of the oat and mushroom beta-glucans
were determined by high performance liquid chromatography (LC-20AT, Shimadzu, Kyoto, Japan) using a refractive index detector (RID-10A, Shimadzu, Kyoto,
Japan). Samples of 100 µL were injected into a Waters
Ultrahydrogel Linear 7.8 × 300 mm size exclusion column (Waters, Milford, MA, USA) that was maintained at
50˚C during measurement. De-ionised water (filtered
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Table 2. Composition of experimental diet.
Group

Composition of Experimental diet
LDO

MDO

HDO

LDM

MDM

HDM

HFD

Carbohydrate (% from total energy)

33

33

33

33

33

34

32

Protein (% from total energy)

16

16

16

16

16

16

16

Fat (% from total energy)

49

49

48

49

49

48

50

Fibre (% from total energy)

2

2

3

2

2

3

2

0.9

2.7

8.1

-

-

-

-

-

-

-

0.7

2.1

6

-

Additional
Oat% (wt:wt)
Mushroom% (wt:wt)
Beta-glucan% (wt:wt)
Daily beta-glucan dose (g)
Energy density (kJ/g)

0.2

0.6

1.8

0.2

0.6

1.8

-

0.2 ± 0

0.7 ± 0.1

1.9 ± 0.3

0.2 ± 0

0.5 ± 0

1.4 ± 0.1

-

18.7

18.6

18.0

18.8

18.8

18.4

18.8

The food was produced from a semi-synthetic material according to the recommendation of “AIN93 diets for laboratory rodents” [30].

Table 3. Viscosities of oat and shiitake mushroom solutions
at different concentrations. The values presented here were
obtained at 45 rpm, except for high dose oat which was
obtained at 0.01 rpm.
Oat
Dose

Shiitake Mushroom

Concentration
Viscosity
Concentration
Viscosity
(mg/ml)
(centipoises)
(mg/ml)
(centipoises)

Low

3

1.623 ± 0.004

2

0.812 ± 0.003

Medium

8

6.425 ± 0.018

6

1.056 ± 0.019

High

25

5089 ± 6.932

18

1.332 ± 0.008

through a 0.45 µm filter membrane) was the mobile
phase, set to flow at 0.7 mL/min. The run time per sample was 30 minutes. Polyethylene glycol (PEG) with different molecular weights (1000, 3000, 4000, 6000, and
8000 dalton) and pure beta-D glucan from Barley (Lot#
BCBC4494V, Sigma Aldrich, Sydney, Australia) with a
molecular weight of 230,000 dalton, were used as standards. The concentrations of the standards were 15 mg/ml.
Oat and mushroom beta-glucan extracts, with concentrations 3 mg/ml and 2 mg/ml respectively (concentration in
Table 3), were run through the HPLC together with the
standards.

2.5. Faecal Weight and Fat Content
In the last week of intervention, faecal samples were collected each day for 3 days from all groups. The faecal
samples from each cage (2 rats per cage) were collected,
weighed and frozen at –80˚C until analysed for fat content. Fat content was analysed according to the modified
procedure described by [31]. In brief, faeces were dried
in a freeze dryer for 48 h. The dried faecal samples were
ground using a mortar and pestle. Fat from the ground
dried faeces was extracted by stirring in chloroform-

methanol 2:1, which was mixed well. The supernatant
was recovered after centrifugation at 3000 rpm for 5
minute at 22˚C. The supernatant was then dried using a
stream of nitrogen. The dried fat was weighed using
analytical balance (AND/HM-300, Japan). The ratio of
faecal fat to faecal weight was calculated as mg faecal fat
per g faecal weight.

2.6. Statistical Analysis
Data were expressed as mean ± standard error of the
mean (SEM). Data were analysis by two way ANOVA.
Dunnet’s method was used to examine the significance
between the control group (HFD) and the treatment groups.
To examine the significance among treatment groups,
contrasts method was used followed by a post hoc-LSD
test. A p value of 0.05 or less was considered significant.
Statistical analysis was performed using SAS 9.1 (SAS
Institute, Cary, NC, USA) and SPSS software (version
17.0, SPSS Inc, Chicago, IL, USA).

3. Results
3.1. Food Intake, Body Weight Gain and Fat
Mass
This study compared the dose response effects of oat and
mushroom enrichment diets on the amount of food intake,
body weight gain (BWG) and fat deposition of rats fed a
high-fat diet (HFD). Food intake did not differ among the
seven groups of dietary intervention (Table 4). The BWG
was significantly affected by both diets and doses (Table
4). The rats fed with the mushroom enrichment diet had
lower BWG compared with the oat enrichment diet (Figure 1; p = 0.003). Furthermore, when comparing between
oats and mushroom powder there was no effect in the
low dose (p = 0.743), but significant effect in the me-
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Figure 1. Body weight gain of male Wistar rats after 6 week
consumption of HFD enriched with oat and mushroom.
Data expressed as mean (±SEM). (*) significant (p = 0.003).
: LD;
: MD;
: HD.

dium dose (–16%, p = 0.040) and in the high dose (–34%,
p = 0.002) groups (Figure 1). The total fat deposition
(epididymal + perirenal + omental + inguinal) was affected by both diets and doses (Table 5). The rats fed a
mushroom enrichment diet had significantly lower total
fat mass than the rats fed an oat enrichment diet (Figure
2(a), p = 0.001). Furthermore, there was no effect in total
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fat mass when comparing the low dose (p = 0.515) and
medium dose (p = 0.117) groups, but significant effects
were seen in the high dose (–41%, p = 0.015) group.
The WAT was affected by the diets and doses (Table
5). The rats fed a mushroom enrichment diet had significantly lower WAT than the rats fed an oat enrichment
diet (Figure 2(b), p = 0.018). Furthermore, there were no
significant effects in WAT when comparing the low dose
and medium dose groups but a trend towards an effect in
the high dose (–32%, p = 0.072) group. The inguinal fat
mass was affected by the diets and doses (Table 5). The
rats fed a mushroom enrichment diet had significantly
lower inguinal fat mass than the rats fed an oat enrichment diet (Figure 2(c), p = 0.006). Furthermore, there
were trends towards effects in the low dose (–30%, p =
0.082), medium dose (–32%, p = 0.086) and high dose
(–47%, p = 0.078) groups. No statistical differences were
found in the amount of other fat mass (epididymal, perirenal, omental, and visceral) deposition between rats fed
a mushroom and rats fed an oat enrichment diet.

3.2. Plasma Triacylglycerol, Total Cholesterol,
High Density Lipoprotein, and Non
Esterified Fatty Acids
Plasma TAG levels were significantly affected by the
diets and doses (Table 6). The rats fed a mushroom en-

Table 4. Food intake and body weight gain in rats fed experimental diets.
Oat group

Mushroom group

Parameter

HFD
LD-O

MD-O

HD-O

LD-M

MD-M

HD-M

Food Intake (g/day)

24 ± 1

26 ± 1

24 ± 1

24 ± 1

24 ± 1

23 ± 1

24 ± 1

Body weight gain (g)

146 ± 13

179 ± 11#

139 ± 11

141 ± 9

150 ± 14

92 ± 8

129 ± 8

ANOVA

Dt; Ds

Values are mean (±SEM). Statistical analysis demonstrated # p < 0.05 compared to HFD. ANOVA, analysis of variance (two way): Dt, significant influence of
diet (p < 0.05); Ds, Significant influence of doses (p < 0.05); HFD, High fat diet; LD-O, low dose oat; MD-O, medium dose oat; HD-O, high dose oat: LD-M,
low dose mushroom; MD-M, medium dose mushroom; HD-M, high dose mushroom.

Table 5. Fat pad masses in rats fed experimental diets.
Oat group

Mushroom group

Parameter
Epididymal

HFD

ANOVA

8±1

11 ± 1

Dt

#

LD-O

MD-O

HD-O

LD-M

MD-M

HD-M

13 ± 1

14 ± 2

12 ± 1

12 ± 1

13 ± 1

Perirenal

16 ± 2

15 ± 2

13 ± 2

14 ± 2

13 ± 2

9±1

14 ± 1

Dt × Ds

Omental

9±1

11 ± 1

11 ± 2

11 ± 1

11 ± 2

7±1

8±1

Dt × Ds

Inguinal fat

9±2

10 ± 2

7±2

7±1

7±2

4±0

8±2

Dt:Ds

Visceral fat (E + P + O)

38 ± 4

40 ± 5

34 ± 4

37 ± 4

34 ± 4

23 ± 2

34 ± 2

Dt, Ds

White adipose tissue (WAT)

49 ± 5

51 ± 7

41 ± 5

44 ± 4

41 ± 4

28 ± 2

42 ± 3

Dt, Ds

Total fat masses

49 ± 5

52 ± 7

41 ± 5

44 ±4

41 ± 4

28 ± 2

43 ± 3

Dt, Ds

ANOVA, analysis of variance (two way): Dt, significant influence of diet (p < 0.05); Ds, Significant influence of doses (p < 0.05); Dt × Ds, significant
interaction between doses and diet (p < 0.05); HFD, High fat diet; LD-O, low dose oat; MD-O, medium dose oat; HD-O, high dose oat: LD-M, low dose
mushroom; MD-M, medium dose mushroom; HD-M, high dose mushroom.
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plasma TAG in rats fed a mushroom enrichment diet in
low (–25%, p = 0.022), medium (–23%, p = 0.035), and
high dose (–27%, p = 0.011) groups compared to rats on
oat enrichment diet. Plasma high density lipoprotein
(HDL) levels were significantly affected by diet (Table
6). The rats fed a mushroom enrichment diet had significantly higher plasma HDL levels than the rats fed an oat
enrichment diet (p = 0.002). There was a trend towards
higher HDL levels in high doses of mushroom enrichment diet compared to the oat enrichment diet (+22%, p
= 0.052). There were no significant effects of diets and
doses on plasma TC and non esterified fatty acids (NEFA)
(Table 6).

Total fat mass (g)

White adipose tissue (g)

1014

(a)

3.3. Oat and Mushroom Beta-Glucan Viscosity
and Molecular Weight

(b)

Inguinal Fat (g)

In order to find the mechanisms for the different effects
of the oat and mushroom enrichment diets, this study
characterized the beta-glucan viscosity and molecular

(c)

Figure 2. The total fat (a); White adipose tissue (WAT) (b)
and Inguinal fat (c) after 6 week’s consumption of HFD
enriched with oat and mushroom. Data expressed as means
(±SEM). (*) significant (a) (p = 0.001); (b) (p = 0.017); (c) (p
= 0.006).
: LD;
: MD;
: HD.

richment diet had significantly lower plasma TAG levels
than the rats fed an oat enrichment diet (Figure 3, p =
0.004). Furthermore, there were significant effects on

Figure 3. The plasma TAG level after 6 weeks consumption
of HFD enriched with oat and mushroom. Data expressed
: LD;
:
as means (±SEM). (*) significant (p = 0.004).
MD;
: HD.

Table 6. Plasma lipid in rats fed experimental diets.
Oat group

Mushroom group

Parameter (mmol/L)

HFD
LD-O

MD-O

HD-O

LD-M

MD-M

ANOVA

HD-M

TC

1.55 ± 0.06

1.66 ± 0.05

1.64 ± 0.08

1.56 ± 0.05

1.52 ± 0.06

1.54 ± 0.07

1.7 ± 0.07

TAG

0.84 ± 0.06

0.83 ± 0.10

0.62 ± 1.06

0.63 ± 0.05

0.71 ± 0.08

0.39 ± 0.00#

0.85 ± 0.10

Dt, Ds

HDL

0.96 ± 0.12

1.05 ± 0.03

1.03 ± 0.03

1.18 ± 0.17

1.06 ± 0.15

1.27 ± 0.06

1.19 ± 0.17

Dt

NEFA

694 ± 46

723 ± 58

697 ± 51

709 ± 90

709 ± 63

723 ± 83

687 ± 63

Values are mean (±SEM). Statistical analysis demonstrated # p < 0.05 compared to HFD. ANOVA, analysis of variance (two way): Dt, significant influence of
diet (p < 0.05); Ds, Significant influence of doses (p < 0.05); TC, total cholesterol; TAG, Triacylglycerol; HDL, high density lipoprotein; NEFA, non esterified
fatty acid; HFD, high fat diet; LD-O, low dose oat; MD-O, medium dose oat; HD-O, high dose oat: LD-M, low dose mushroom; MD-M, medium dose
mushroom; HD-M, high dose mushroom.
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weight from the oats and mushrooms. Generally, both the
oat and shiitake mushroom beta-glucans showed sheer
thinning behavior where the viscosity decreased with
higher speed. At low speed, they also showed thixotropic
behavior where the viscosity decreased over time under
constant shear rate. Due to the variety of speeds used (to
ensure that the torque exerted on the liquid was between
the manufacturer’s recommended range), for comparison,
the viscosity data at 45 rpm is presented (Table 3). At
this speed, the viscosity of the oat beta-glucan, at the
concentrations studied in this work, was considerably
higher than that of the mushroom. The viscosity of mushroom beta-glucan even at the highest concentration (18
mg/ml) was lower than that of oat beta-glucan at the lowest concentration (3 mg/ml), suggesting that viscosity is
not the reason that mushroom beta-glucan is more effective to prevent weight gain and fat accumulation than oat
beta-glucan. The viscosity data of high dose beta-glucan
in oat solution (25 mg/ml) is shown separately because
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its value is 1000-fold higher (Table 3). Size exclusion
chromatography data showed that both the Shiitake mushroom and oat extracts contained high molecular weight
polymers, with those from Shiitake mushrooms larger than
those from oats (Figure 4).

3.4. The Weight of Faeces and Total Lipid in
Faeces
The faecal weights were significantly affected by the
diets and doses (Table 7). The only diet that was statistically different to HFD was HD-O group showing a 24%
reduction in faecal weight (Table 7).
The faecal fat weight to faecal weight ratio was significantly affected by doses in rats fed either mushroom
or oat enrichment diets (Table 7). The faecal fat weight
to faecal weight ratio was 16% higher in HD-M enrichment diet compared to HD-O (p = 0.026). However, no
differences in faecal fat weight to faecal weight ratio

Figure 4. The high performance liquid chromatography (HPLC) profiles of -glucan solutions extracted from oat and shitake
mushroom and pure  D-glucan from Barley.
Table 7. Plasma lipid in rats fed experimental diets.
Oat group

Parameter
Faecal weight (g)/24 h
Faecal fat/24 h faecal weight

Mushroom group

LD-O

MD-O

HD-O

LD-M

MD-M

HD-M

3.9 ± 0

3.5 ± 0.0

3.1 ± 0.2#

3.9 ± 0.1#

3.7 ± 0.2

3.9 ± 0.3

12 ± 0

13 ± 0

16 ± 0

#

12 ± 0

12 ± 0

19 ± 0

#

HFD

ANOVA

4.1 ± 0

Dt; Ds

12 ± 0

Ds; Dt × Ds

#

Values are mean (±SEM). Statistical analysis demonstrated p < 0.05 compared to HFD. ANOVA, analysis of variance (two way): Dt, significant influence of
diet (p < 0.05); Ds, Significant influence of doses (p < 0.05); Dt × Ds, significant interaction between doses and diet (p < 0.05); HFD, high fat diet; LD-O, low
dose oat; MD-O, medium dose oat; HD-O, high dose oat: LD-M, low dose mushroom; MD-M, medium dose mushroom; HD-M, high dose mushroom.
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were found between rats fed the same amount of low and
medium doses of mushroom and oat enrichment diets.

4. Discussion
The present study for the first time found that rats fed a
HFD enriched with shiitake mushroom powder had
stronger effects in lowering body weight gain, fat deposition and plasma TAG, and compared with oat powder.
To determine the beneficial effect of shiitake mushrooms,
dosage must also be considered. This study showed that a
high dose of mushroom enriched diet led to more exclusion of fat in the faeces compared to a high dose of oat
enriched diet.
In general, animal studies have been previously reported in the literature and these showed that mushroom
enriched diet had an effect on body weight gain prevention [24,32-34]. The data of BWG prevention by mushroom was depending on the rat species [22,32,34,35],
dosages in the diet and the variety of mushroom [32,33,
35-38]. There are no reported clinical trials in mushroom
enriched diet to prevent BWG in humans.
The clinical study of oat enriched diet to prevent body
weight gain was not largely reported, even though oat
enrichment diet has been studied in different studies with
different initial plasma lipid levels [5,7,11-14], doses of
additional oat [8,11,12], length of treatment [5,7,12,13]
and food matrix [5,7] all of which cannot achieve the
constructive effect to prevent body weight gain. However
a clinical study in oat enrichment diet reported decrease
BWG when oat gives concurrently with exercise and low
fat diet for 8 weeks [6]. Furthermore enriched oat in animal model diet showed decreasing in body weight gain
when 20% oat bran concentrate enriched diet have 43%
beta glucan content [10]. However, enrichment 4% and
8% oat beta glucan for replacing cellulose on hamster fed
hypercholesterolemic diet did not affect on BWG [39].
There are very few studies that investigated the effect
of oats and mushroom powder as part of a HFD on fat
deposition. This current study showed that mushroom
powder (HD-M) was more effective than oat powder (HDO) in lowering total fat mass (35% vs 5%), WAT (33%
vs 2%) and inguinal fat (50% vs 13%). Similar results
were reported by [34] an additional 20% of Maitake
mushrooms in rats fed a cholesterol diet decreased 43%
fat deposition. On the other hand no studies have reported the effect of oat enrichment diet on fat deposition.
It has been reported in the literature that mushroom
and oat enriched diets have the effect of lowering plasma
TAG in humans and animals. For example, mushroom
enriched diets significantly lowered plasma TAG level in
animal studies [22,23,33-35,40] and a human study [15],

evidence from oat enriched diets showed that more than
20% of oats in the diet is necessary to achieve TAG lowering effects in rats [9]. Another study reported, the effect of an additional 20% oats with different molecular
weight (370.000 g/mol - 1450.000 g/mol) in mice fed
HFD had a significant effect on lowering plasma TAG
level [10]. However, in human studies, additional oats in
the diet had no effect on plasma TAG lowering effect [58,11-13,17]
It is well known that lowering plasma TAG will decrease the fatty acid (FA) circulation, so it will decrease
the source of fatty acid in adipose tissue through the adipogenesis process [41]. This was also reported by Novelli
[4] that the increasing of plasma TAG level in rats fed
HFD promoted fat deposition and BWG.
This current study showed that HD-M and HD-O resulted in 58% and 33%, respectively, increase in faecal
fat excretion per faecal weight compared to HFD. Studies
have found that 40% oat enriched diets significantly increased faecal cholesterol fourfold increase in mice fed a
high fat diet accompanied by a decreased plasma TC and
TAG levels [9]. A clinical study also reported that an oat
bran diet in healthy subjects increased fat in faeces 57%
more than a wheat bran diet [42]. Again, Cheung [36]
reported hamsters fed HFD and Straw mushrooms enrichment significantly increased faecal sterol 81% more
than hamsters fed the control diet (HFD and cellulose)
which was accompanied by a significant 36% TC lowering effect.
Some studies reported the improvement in dyslipidaemia by beta-glucan was due to viscosity [7,16,17].
Both beta-glucan from oats [43,44] and mushrooms [45]
can slow down the digestion transit time in the lower part
of the small intestine and in the large intestine, therefore
delaying nutrient absorption. This study measured both
oat and mushroom beta-glucan molecular weight before
these were added and mixed to the rat food. The results
showed that MW in Shiitake mushroom beta glucan was
higher than oat beta glucan used in this study. However,
it is uncertain whether the viscosity of oats or mushrooms alone would be similar to the actual viscosity of
rat food after it was added to oats or Shiitake mushrooms.
This is because in food enriched with oats and Shiitake
mushrooms viscosity was affected by the food preparation, such as food stored in a frozen state, and the digestion process that could decrease the MW of beta-glucan.
For instance, the freeze-thaw process will decrease
MW by 40% and the digestion process will decrease by
100,000 Dalton [46]. In this study, the rat foods were
frozen before being given to rats. As the mushroom MW
was greater than oat MW, after the freeze-thaw process
and digestion, the MW of the oats was expected to remain <1,000,000 Dalton and the MW of the mushrooms
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was expected to remain >1,000,000 Dalton. Although the
correlation of MW and the effect of viscosity were still
doubtful, Tosh, Brummer et al. [47] reported that in order to achieve the viscosity effect of beta-glucan, the
MW should be >1,000,000 Dalton. Kerckhoffs, Hornstra
et al. [7] also reported that a MW of beta-glucan
<1,200,000 Dalton could still lower plasma lipid if administered with a drink. Therefore the viscosity in oats
and Shiitake mushrooms tested before they were added
to the rat food may not be able to explain the different
effects of oat and Shiitake mushroom enriched diets in
lowering plasma lipid levels in vivo.
Shiitake mushroom powder contains other active ingredients such as eritadenine and chitin. Eritadenine may
contribute to the effect by inhibiting the plasma TAG
derived lipoprotein release from the liver [48,49]. The
concentration of eritadenine is about 0.36% in Shiitake
mushroom powder [29]. The HD-M diet used in this
study contains ~200 mg eritadenine/kg food. Sugiyama
[18] reported that an additional 50 mg eritadenine in choline deficient rats lowered plasma lipid by –68% and
–83% of plasma TC and TAG respectively.
Chitin is insoluble in water and grouped as functional
fibre to lower blood lipids [50,51]. However, chitin needs
to be converted to chitosan to lower plasma lipid levels
[52]. The process of converting chitin to chitosan is by
alkaline hydrolysis (45% NaOH, 100˚) [53]. Hence this
conversion is unlikely to have occurred in vivo, and therefore chitin is unlikely to explain the reduction in plasma
TAG in this study.
Accordingly, this result and references suggest the
lowering of plasma TAG levels in HD-M has possibly
also been affected by eritadenine. This reason was supported by data that showed that although the fat faecal
exclusion both of HD-M and HD-O were not significantly different the plasma TAG level, fat mass deposition and body weight gain between HD-O and HD-M
were significantly different. Therefore other mechanisms
possibly promoted the lowering of plasma TAG levels in
HD-M.

5. Conclusion
In summary, the mushroom diet is better than the oat diet
as part of a HFD because it reduces BWG, total fat mass,
plasma TAG and increased fat faecal excretion. The
dosage required for these effects was the HD-M (1.8%
wt:wt beta glucan from mushroom or 6% mushroom
powder) with lower doses having minimal effects. The
potential reason why mushrooms were better than oats
was possibly its chemical structure. Food enriched with
Shiitake mushroom was more stable and retained viscosity effects after the freeze-thaw process compared to food
enriched with oats. In addition, Shiitake mushrooms also
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contain another potential biological component, namely
eritadenine.
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